The Impact of COVID-19 is included in Live Attenuated Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Live Attenuated Vaccine Trends and Forecast
The future of the global live attenuated vaccine market looks promising with opportunities in the hospital, clinic, diagnostics center, and research institute markets. The global live attenuated vaccine market is expected to reach an estimated $9.8 billion by 2030 with a CAGR of 9.5% from 2024 to 2030. The major drivers for this market are cumulating need for more effective vaccines, expanding awareness of the benefits of vaccination, and supportive government initiatives to promote vaccination programs.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Live Attenuated Vaccine by Segment
The study includes a forecast for the global live attenuated vaccine by type, end use, and region.
Live Attenuated Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Bacterial
• Viral
Live Attenuated Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospital
• Clinic
• Diagnostic Center
• Research Institute
• Others
Live Attenuated Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Live Attenuated Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies live attenuated vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the live attenuated vaccine companies profiled in this report include-
• Glaxosmithekline
• Merck & Co
• Medimmune
• Sanofi
• Serum Institute India
• Emergent Biosolutions
• CSL
Live Attenuated Vaccine Market Insights
Lucintel forecasts that viral is expected to witness higher growth over the forecast period due to its significant usage for the effective prevention of viral infections.
Within this market, hospital is expected to witness highest growth over the forecast period.
North America is expected to witness highest growth over the forecast period due to the existence of well developed healthcare infrastructure and presence of supported government vaccination campaigns among individuals in the region.
Features of the Global Live Attenuated Vaccine Market
Market Size Estimates: Live attenuated vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Live attenuated vaccine market size by type, end use, and region in terms of value ($B).
Regional Analysis: Live attenuated vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the live attenuated vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the live attenuated vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the live attenuated vaccine market size?
Answer: The global live attenuated vaccine market is expected to reach an estimated $9.8 billion by 2030.
Q.2 What is the growth forecast for live attenuated vaccine market?
Answer: The global live attenuated vaccine market is expected to grow with a CAGR of 9.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the live attenuated vaccine market?
Answer: The major drivers for this market are cumulating need for more effective vaccines, expanding awareness of the benefits of vaccination, and supportive government initiatives to promote vaccination programs.
Q4. What are the major segments for live attenuated vaccine market?
Answer: The future of the live attenuated vaccine market looks promising with opportunities in the hospital, clinic, diagnostics center, and research institute markets.
Q5. Who are the key live attenuated vaccine market companies?
Answer: Some of the key live attenuated vaccine companies are as follows:
• Glaxosmithekline
• Merck & Co
• Medimmune
• Sanofi
• Serum Institute India
• Emergent Biosolutions
• CSL
Q6. Which live attenuated vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that viral is expected to witness higher growth over the forecast period due to its significant usage for the effective prevention of viral infections.
Q7. In live attenuated vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to the existence of well developed healthcare infrastructure and presence of supported government vaccination campaigns among individuals in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the live attenuated vaccine market by type (bacterial and viral), end use (hospital, clinic, diagnostics center, research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to live attenuated vaccine market or related to live attenuated vaccine companies, live attenuated vaccine market size, live attenuated vaccine market share, live attenuated vaccine market growth, live attenuated vaccine market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Live Attenuated Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Live Attenuated Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Live Attenuated Vaccine Market by Type
3.3.1: Bacterial
3.3.2: Viral
3.4: Global Live Attenuated Vaccine Market by End Use
3.4.1: Hospital
3.4.2: Clinic
3.4.3: Diagnostic Center
3.4.4: Research Institute
3.4.5: others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Live Attenuated Vaccine Market by Region
4.2: North American Live Attenuated Vaccine Market
4.2.2: North American Live Attenuated Vaccine Market by End Use: Hospital, Clinic, Diagnostic Center, Research Institute, and Others
4.3: European Live Attenuated Vaccine Market
4.3.1: European Live Attenuated Vaccine Market by Type: Bacterial and Viral
4.3.2: European Live Attenuated Vaccine Market by End Use: Hospital, Clinic, Diagnostic Center, Research Institute, and Others
4.4: APAC Live Attenuated Vaccine Market
4.4.1: APAC Live Attenuated Vaccine Market by Type: Bacterial and Viral
4.4.2: APAC Live Attenuated Vaccine Market by End Use: Hospital, Clinic, Diagnostic Center, Research Institute, and Others
4.5: ROW Live Attenuated Vaccine Market
4.5.1: ROW Live Attenuated Vaccine Market by Type: Bacterial and Viral
4.5.2: ROW Live Attenuated Vaccine Market by End Use: Hospital, Clinic, Diagnostic Center, Research Institute, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Live Attenuated Vaccine Market by Type
6.1.2: Growth Opportunities for the Global Live Attenuated Vaccine Market by End Use
6.1.3: Growth Opportunities for the Global Live Attenuated Vaccine Market by Region
6.2: Emerging Trends in the Global Live Attenuated Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Live Attenuated Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Live Attenuated Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Glaxosmithekline
7.2: Merck & Co
7.3: MedImmune
7.4: Sanofi
7.5: Serum Institute India
7.6: Emergent Biosolutions
7.7: CSL
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Live Attenuated Vaccine Market Report.